drugset / Trial / NCT07597018

A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity

NCT07597018 ↗

Phase 1 Recruiting 234 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This clinical study is testing two versions of the study medicine cagrilintide. The purpose of the study is to compare these two versions to understand their effects in participants with overweight or obesity. Participants will receive either cagrilintide version D or cagrilintide version B, and which treatment participants receive is decided by chance. Participants will be in this clinical study for about 6 months.

Timeline

Start
2026-05-18
Primary completion
2027-05-28
Completion
2027-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cagrilintide B Unknown — Subcutaneous
Subject Cagrilintide D Unknown — Subcutaneous

Indications